• 1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 2. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 3. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
• 4. An ionic liquid-based synergistic extraction strategy for rare earths?
  Yingbo Li,Nada Mehio,Huizhou Liu,Sheng Dai Green Chem., 2015,17, 2981-2993
• 5. Aggregation dynamics, structure, and mechanical properties of bigels
  L. Di Michele,D. Fiocco,F. Varrato,E. Eiser,G. Foffi Soft Matter, 2014,10, 3633-3648

Professional Introduction to N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine (CAS No. 99806-91-4)

N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine, a compound with the CAS number 99806-91-4, represents a significant area of interest in the field of pharmaceutical chemistry and organic synthesis. This compound, characterized by its unique structural and chemical properties, has garnered attention for its potential applications in drug development and synthetic chemistry. The presence of a naphthalene moiety and a methylidenehydroxylamine functional group makes it a versatile intermediate in the synthesis of various bioactive molecules.

The naphthalene ring, a fused aromatic hydrocarbon consisting of two benzene rings, contributes to the compound's stability and reactivity. The methoxynaphthalen-1-yl substituent introduces a polar ether group, enhancing solubility and interaction with biological targets. The methylidenehydroxylamine part, on the other hand, provides a reactive site for further functionalization, making it valuable in constructing more complex molecules. These structural features have positioned N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine as a key building block in medicinal chemistry.

In recent years, the pharmaceutical industry has seen a surge in the development of novel therapeutic agents derived from heterocyclic compounds. Among these, naphthalene derivatives have been extensively studied due to their diverse biological activities. Research has shown that compounds containing the naphthalene scaffold exhibit properties such as anti-inflammatory, anticancer, and antimicrobial effects. The specific modifications on the naphthalene ring can significantly alter its pharmacological profile, making it possible to fine-tune the activity towards specific therapeutic targets.

The synthesis of N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine involves multi-step organic reactions that highlight the compound's synthetic utility. The process typically begins with the functionalization of the naphthalene ring to introduce the methoxy group followed by the attachment of the hydroxylamine moiety through condensation reactions. Advanced synthetic methodologies, including palladium-catalyzed cross-coupling reactions and transition-metal-catalyzed hydrogenation, have been employed to achieve high yields and purity. These techniques underscore the compound's importance in modern synthetic chemistry.

One of the most compelling aspects of N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine is its potential as a scaffold for drug discovery. Researchers have leveraged its structural features to develop novel molecules with enhanced pharmacological properties. For instance, studies have demonstrated that derivatives of this compound exhibit significant inhibitory activity against various enzymes implicated in diseases such as cancer and neurodegeneration. The ability to modify both the naphthalene ring and the methylidenehydroxylamine group allows for extensive structural diversification, facilitating the identification of potent lead compounds.

The role of computational chemistry in optimizing the synthesis and properties of N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine cannot be overstated. Molecular modeling techniques have been instrumental in predicting binding interactions with biological targets and designing derivatives with improved efficacy. Additionally, computational methods have helped in identifying optimal reaction conditions for its synthesis, reducing costs and improving yields. This integration of experimental and computational approaches exemplifies the modern paradigm in pharmaceutical research.

Recent advancements in biocatalysis have also opened new avenues for utilizing N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine in drug development. Enzymatic transformations offer a sustainable and efficient alternative to traditional synthetic methods, particularly for introducing complex functionalities into molecular frameworks. Studies have explored the use of engineered enzymes to modify this compound selectively, enhancing its suitability for medicinal applications. Such innovations align with global efforts to promote green chemistry principles in pharmaceutical manufacturing.

The future prospects of N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine are promising, given its versatility as a synthetic intermediate and its potential therapeutic applications. Ongoing research aims to uncover new derivatives with improved pharmacokinetic profiles and reduced side effects. Collaborative efforts between academia and industry are essential to translate these findings into tangible therapeutic benefits for patients worldwide. As our understanding of molecular interactions deepens, compounds like N-(2-methoxynaphthalen-1-yl)methylidenehydroxylamine will continue to play a pivotal role in shaping next-generation medicines.

• 29577-53-5(2-Methoxybenzaldehyde Oxime)
• 31874-34-7(2,4-Dimethoxybenzaldoxime)
• 34967-19-6(N-(2,5-dimethoxyphenyl)methylidenehydroxylamine)
• 51903-38-9((E)-N-(2,4,6-trimethoxyphenyl)methylidenehydroxylamine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)